Ato drug
Pro Research Analysisby 
Searched over 200M research papers for "ato drug"
ATO Drug: Applications and Implications in Medicine
Compritol 888 ATO in Drug Delivery Systems
Lipid-Based Drug Delivery
Compritol 888 ATO, a lipid excipient, is widely used in the cosmetic industry and has recently garnered attention for its potential in pharmaceutical applications. It is primarily utilized in lipid-based colloidal drug delivery systems, such as solid lipid microparticles, nanoparticles, and nanostructured lipid carriers. These systems benefit from Compritol 888 ATO's ability to act as a lubricant, coating agent, and matrix-forming agent, which helps in controlling drug release.
Regulatory and Safety Profiles
Despite its promising applications and acceptable safety profiles, Compritol 888 ATO is not yet widely adopted in the pharmaceutical market. Its primary use remains in extended-release tablets due to its sustained release capabilities.
Arsenic Trioxide (ATO) in Cancer Treatment
Mechanisms and Efficacy
Arsenic trioxide (ATO) is a well-established treatment for acute promyelocytic leukemia (APL), where it induces degradation of the PML/RARα fusion protein, leading to cell differentiation and apoptosis. However, its efficacy in treating non-APL malignancies and solid tumors is less pronounced when used as a single agent .
Combination Therapies
Combining ATO with other therapeutic agents has shown promising results in enhancing its efficacy against various cancers, including lung cancer. These combinations can inhibit cancer stem-like cells, induce apoptosis, and enhance the effects of chemotherapy and radiotherapy .
Genomic Insights and Resistance
Genome-wide CRISPR-Cas9 screening has identified key pathways and genes, such as KEAP1, that influence ATO sensitivity. KEAP1 is associated with oxidative stress, metabolism, and immune responses, and its expression levels correlate with patient outcomes in acute myeloid leukemia (AML).
Atorvastatin (ATO) in Hypercholesterolemia and Beyond
Hepatic and Renal Toxicity
Atorvastatin, a statin used to lower cholesterol, has been linked to dose-dependent hepatic and renal toxicity. This toxicity is mediated through oxidative stress, mitochondrial dysfunction, and activation of apoptotic pathways involving MAPKs, caspases, and calpain .
Protective Measures
Studies have shown that compounds like arjunolic acid can mitigate atorvastatin-induced toxicity by reducing oxidative stress and suppressing apoptotic signaling, thereby protecting liver and kidney tissues.
Potential in Chronic Lung Diseases
Beyond its lipid-lowering effects, atorvastatin has demonstrated anti-inflammatory, antioxidant, and anti-proliferative properties, making it a potential candidate for treating chronic lung diseases. Its formulation as an inhaler could offer new therapeutic avenues for respiratory conditions.
Atomoxetine (ATO) in Addiction Treatment
Preventing Relapse
Atomoxetine, a selective norepinephrine reuptake inhibitor, has shown efficacy in preventing relapse in drug addiction. It significantly reduces cue-induced seeking behaviors for both heroin and cocaine, making it a promising treatment for preventing relapse in stimulant and opiate addiction.
Conclusion
The diverse applications of ATO drugs, from lipid-based drug delivery systems to cancer treatment and addiction prevention, highlight their multifaceted roles in modern medicine. While promising, the full potential of these drugs requires further exploration and optimization to balance efficacy and safety across various therapeutic contexts.
Sources and full results
Most relevant research papers on this topic